Three-Drug attack on tough cancers shows promise
NCT ID NCT02484404
Summary
This study is testing whether combining two or three different cancer drugs works better than single drugs to control advanced cancers that have come back or spread. It is for adults with advanced ovarian, breast, lung, prostate, or colorectal cancer who have few other treatment options. The goal is to see if these combinations can help the immune system fight cancer while also damaging cancer cells in other ways.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST NEOPLASMS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
National Institutes of Health Clinical Center
Bethesda, Maryland, 20892, United States
Conditions
Explore the condition pages connected to this study.